Guidelines of guidelines: a review of urethral stricture evaluation, management, and follow-up

Abstract

Background

Our objective is to report a comparative review of recently released guidelines for the evaluation, management, and follow-up of urethral stricture disease.

Methods

This is an analysis of the American Urologic Association (AUA) and Société Internationale d’Urologie (SIU) guidelines on urethral stricture. Strength of recommendations is stratified according to letter grade that corresponds to the level of evidence provided by the literature.

Results

Although few, the discrepancies between the recommendations offered by the two guidelines can be best explained by varying interpretations of the literature and available evidence on urethral strictures. When comparing the AUA guidelines and the SIU guidelines on urethral stricture, there are very few discrepancies. Perhaps the most notable difference is in the use of repeat DVIU or urethral dilation after an initial failed attempt. SIU guidelines state that there are instances where repeat DVIU or urethral dilation can be indicated, and they give a range of time at which stricture recurrence post procedure mandates an urethroplasty (less than 3 to 6 months). The AUA guidelines definitively state that repeat endoscopic procedures should not be offered as an alternative to urethroplasty, and they do not mention time of stricture recurrence as a factor. SIU guidelines allow for management of urethral stricture with indwelling urethral stenting.

Conclusions

Overall there is a need for more high quality research in the work up, management, and follow up care of urethral stricture.

Introduction

An urethral stricture is an abnormal narrowing of the urethra resulting from fibrosis in the surrounding corpus spongiosum (1). The most common etiology of urethral strictures is idiopathic, followed by iatrogenic causes, including transurethral resection, urethral catheterization, prostate cancer treatments, and previous hypospadias surgery (2). Urethral strictures are known sequela of pelvic and perineal trauma (1,2). The annual costs due to urethral strictures in the United States are estimated to be about $200 million dollars with approximately 5,000 new inpatient visits yearly (3). In the United Kingdom, it is estimated that 700 urethroplasties and 16,000 urethrotomy and dilation procedures are performed annually (4). The costs associated with urethral strictures are compounded by patient morbidity, including urinary tract infections (UTIs), incontinence, and stricture recurrence (2). Recently, the American Urological Association (AUA) released guidelines on the evaluation, management, and follow-up of urethral strictures (5). Prior to this, the only other professional society to put forth guidelines on urethral strictures was Société Internationale d’Urologie (SIU) in 2010 (6). Our objective is to report a side-by-side comparative review summarizing the AUA and SIU guidelines for the evaluation, management, and follow-up of urethral stricture disease.

Strength of recommendations is stratified according to letter grade that corresponds to the level of evidence provided by the literature (Table 1). Where available, the grade of recommendation is given. Both AUA and SIU use this scale (7) (Table 2). Grade A recommendations are derived from level 1 evidence or a large body of level two evidence. Level 1 evidence corresponds to meta-analysis of randomized control trials (RTCs), a single good-quality RTC, or very strong studies involving a single treatment option. Level 2 evidence is based on low-quality RCTs (less than 80% follow up) or meta-analysis of prospective cohort studies. Grade B recommendations are drawn from level 2 or 3 evidence or majority evidence from RTCs. Level 3 evidence is based on appropriately matched retrospective case-control or case series studies. Grade C recommendations are drawn from level 4 evidence. Level 4 evidence is expert opinion corresponding to basic physiological or anatomical principals, or bench research (6). Clinical principal is based on widely agreed opinion among urologists that may or may not be evidence based. Expert opinion is a derived from consensus agreement among experts based on clinical training, experience, or knowledge (6,7).

Table 1. Strength of recommendation.

Recommendation level	Evidence
Grade A	Well-conducted RCT or exceptionally strong observational study
Grade B	RCT with some weakness of procedure or generalizability or generally strong observational studies
Grade C	Observational studies that are inconsistent, have small sample sizes, or have other problems that potentially confound interpretation of data
Clinical principle	Statement about a component of clinical care that is widely agreed upon by urologists or other clinicians for which there may or may not be evidence in the medical literature
Expert opinion	Statement, achieved by consensus of a panel, based on members’ clinical training, experience, knowledge

Table 2. Recommendations by management category.

Management category	AUA	Both	SIU
Clinical evaluation	Stricture is in the differential in a patient presenting with LUTS*	Symptoms, patient-reported outcomes and uroflow can be helpful in diagnosis#^	Uroflow is unreliable in pediatric patients^
Radiographic & cystoscopic evaluation	In non-urgent situations, determine length and location of stricture#	RUG/VCUG and cystoscopy are the best tests for diagnosis and characterization*+; ultrasound can be used for spongiofibrosis and stricture length*	MRI/CT can be used as an adjunct*
Endoscopic management	Catheter removal within 72 hours after DVIU*; recommend against repeat DVIU+	DVIU & dilation have equivalent outcomes*; DVIU can be offered for untreated, short (<2 cm) bulbar strictures*+; repeat DVIU with CIC can be palliative*^	Repeat DVIU can be considered with favorable strictures if time to recurrence is >3 months^; avoid DVIU in obliterative strictures & pediatric patients+; repeat DVIU can exacerbate spongiofibrosis^
Urethroplasty	Urethroplasty should be done by experts or patients referred to experts#; meatal strictures can be treated with initial dilation/meatotomy but recurrences should undergo urethroplasty*; buccal mucosa is the graft of choice#	Long (>2 cm), previously treated or penile strictures should be treated with urethroplasty*^; do not tubularize grafts#+; skin flaps can be used but avoid hair bearing skin#+; avoid allografts or xenografts#^	EPA has high success rate for short bulbar strictures+; success rate of EPA is greater than substitution urethroplasty+; success rates of EPA for longer strictures (2–4 cm) are higher in the proximal bulbar urethra^; grafts are preferred over flaps^; hypospadias strictures should be treated with urethroplasty^
Pelvic fracture urethral injury	Delayed formal reconstruction should be performed after major injuries are stabilized and is preferred over delayed endoscopic management#; prior to reconstruction, RUG/VCUG/cystoscopy should be performed to assess stricture characteristics*	–	Rule out UI with blood at meatus+; suspect UI with pelvic fracture+; RUG is the test of choice+; DRE unreliable for UI^; in stable patients, one can attempt a gentle catheter placement^; early on, endoscopic realignment can be attempted^; early urethroplasty should be avoided except with concurrent rectal/bladder neck injury+
Bladder neck contracture	Open reconstruction is an option for recalcitrant BNC*	BNC can be managed endoscopically*	–
Lichen sclerosis	Biopsy when cancer is suspected#	Use buccal mucosa to reconstruct urethral stricture, not genital skin+^	If LS is confined to glans/foreskin, topical steroids and circumcision are appropriate+; do not use colonic or bladder mucosa*; long term follow up is needed secondary to risk of malignancy^
Alternatives to urethroplasty	Perineal urethrostomy is an option for strictures*	–	Urethral stenting can be offered to patients who cannot tolerate urethroplasty or CIC^
Follow up	Important to monitor for symptomatic stricture recurrence#	–	Urethrography or urethroscopy can be used to monitor recurrence+

PFUI, pelvic fracture and urethral injury; DVIU, direct vision internal urethrotomy; VCUG, voiding cystourethrogram; LS, lichen sclerosis; RUG, retrograde urethrogram; EPA, excision primary anastomosis; MRI, magnetic resonance imaging; CT, computed tomography; LUTS, lower urinary tract symptoms; CIC, clean intermittent catheterization. ⁺, Grade A; ^{^}, Grade B; *, Grade C; ^#, clinical principal/expert opinion. If 2 grades are listed, AUA is listed first.

Evaluation of urethral strictures

Clinical evaluation

Presenting symptoms of urethral strictures often include decreased urinary stream, incomplete emptying, dysuria, UTI, and/or a rising post void residual (PVR) (5). Other urological conditions, including bladder outlet obstruction from prostatic enlargement, may mimic symptoms of urethral strictures. Common risk factors for developing an urethral stricture include any transurethral surgery, pelvic and perineal trauma, urethral catheterization, prostate cancer treatment, a history of hypospadias repair, and/or lichen sclerosus (LS) (2,8). The AUA guidelines recommend considering an urethral stricture in the differential diagnosis when any male patient presents with the symptoms listed above (AUA; Grade C). The SIU guidelines do not directly comment on the differential diagnosis of urethral stricture disease. Both guidelines recommend the use of patient reported measures, such as the American Urological Association Symptom Index (AUA-SI) and uroflowmetry to evaluate a suspected urethral stricture (AUA; clinical principle) (SIU; Grade B). In particular, the presence of a reduced peak flow (9) places a patient at higher risk for an urethral stricture and further imaging is then indicated (AUA; clinical principle). AUA-SI should be used as an adjunct measure in the initial diagnosis and should not be used alone to diagnose or exclude a stricture (SIU; Grade C).

Radiographic and endoscopic evaluation

Typical options for evaluation of urethral stricture include urethroscopy, retrograde urethrography (RUG), voiding cystourethrography (VCUG), and ultrasound. The AUA guidelines state that radiographic or endoscopic evidence is necessary to make the diagnosis of an urethral stricture, however they do not imply superiority of one individual test to make a definitive diagnosis (AUA; Grade C). The SIU guidelines advocate for a RUG (SIU; Grade A), VCUG (SIU; Grade B), cystoscopy (SIU; Grade A) and/or ultrasound (SIU; Grade C). A RUG generally allows the physician to identify the location and length of the stricture and shows the presence of other urethral pathology such as fistulas or calculi (10). While the AUA reports that RUG is the study of choice for urethral stricture diagnosis, it is highly operator-dependent (11). Cystoscopy is the most specific procedure for the diagnosis of an urethral stricture (12) (SIU; Grade A); however, it is limited as stricture length cannot be determined.

Ultrasound may be used to determine the extent of spongiofibrosis and absolute stricture length (13) (AUA; Grade C), but its use is recommended in conjunction with RUG for preoperative staging and length assessment of anterior urethral strictures (SIU; Grade C). SIU guidelines also mention the use of magnetic resonance imaging (MRI) and computed tomography (CT) as useful adjuncts for the evaluation of urethral stricture, particularly in the setting of pelvic fracture (SIU; Grade C). The AUA guidelines add that in a setting where non-urgent intervention is appropriate, determining length and location of the urethral stricture is recommended (AUA; expert opinion).

Surgical management of urethral stricture

Endoscopic management

Both the AUA (AUA; Grade C) and the SIU (SIU; Grade C) state that both dilation and direct visual internal urethrotomy (DVIU) can be offered in the management of urethral strictures, and the SIU states that both urethral dilation and DVIU have equivalent clinical efficacy (14) (SIU; Grade B). Laser urethrotomy provides no advantage over cold knife procedures and is more costly, therefore laser procedures are not recommended (SIU; Grade A).

DVIU or dilation has a success rate of 50–60% when used as an initial procedure to treat urethral strictures of less than or equal to 2 cm (14,15). Both AUA (AUA; Grade C) and SIU guidelines (SIU; Grade A) state that DVIU or dilation is an appropriate initial procedure in bulbar urethral strictures of 2 cm or less. The AUA guidelines also mention that urethroplasty can be used for first time treatment of bulbar urethral strictures less than 2 cm (AUA; Grade C). For penile, penobulbar, multiple, and/or longer strictures, urethroplasty should be offered as initial management given the low success rate of endoscopic management (AUA; Grade C). SIU guidelines comment specifically that urethral reconstruction instead of DVIU or dilation is indicated for obliterative or near obliterative strictures (SIU; Grade A). In pediatric urethral strictures, DVIU or dilation is not recommended as a first line treatment given the high stricture recurrence rate (67–78% recurrence over 6 years) (16) (SIU; Grade A), and urethroplasty should be offered as the primary intervention.

According to the SIU guidelines, repeat DVIU or dilation is acceptable in favorable conditions such as solitary strictures, bulbar urethral strictures, length less than 2 cm, and stricture recurrence greater than 3 to 6 months after the previous treatment (SIU; Grade B). Recurrent stricture at 3 months or less after initial DVIU or dilation is predictive of poor success rate with second dilation and found to have no value after 48 months. On the other hand, if the stricture recurs more than 6 months after the initial procedure, repeat DVIU or dilation may produce a stricture free rate of 40% at 48 months (17). The AUA guidelines definitively state that urethroplasty is recommended over a second DVIU or dilation (AUA; Grade C). They do not make any stipulations on time of recurrence and therapy choice. More than one DVIU or dilation has proven to be cost ineffective compared to a definitive urethroplasty (SIU; Grade A). The SIU does state that a third DVIU or dilation should not be offered with the exception of situations limited by patient comorbidities or resource availability (SIU; Grade A). Repeat endoscopic procedures carry the risk of exacerbating spongiofibrosis and complicating definitive urethroplasty (SIU; Grade B). In fact, data suggests that prior endoscopic treatment for urethral stricture is an independent risk factor for stricture recurrence after urethroplasty (18).

In the setting of acute urinary retention, DVIU, urethral dilation, or suprapubic cystotomy is permitted as a temporizing intervention prior to urethroplasty (AUA; expert opinion). These can also be used as palliative measures combined with clean intermittent catheterization for patients who are unfit for major urethral reconstructive procedures (SIU; Grade B) (AUA; Grade C). After uncomplicated urethral dilation or DVIU, a catheter should be placed after the procedure and can be safely removed within 72 hours (AUA; Grade C).

Urethroplasty

Urethroplasty is the definitive procedure for urethral stricture disease. Urethroplasty has a success rate of up to 95% (19-21) with experienced surgeons. Surgeons who do not perform urethroplasty should refer patients to a surgeon with expertise in urethroplasty when indicated (AUA; expert opinion).

Bulbar strictures

For short strictures of the bulbar urethra, less than 2 cm, excision and primary anastomosis (EPA) urethroplasty is highly successful with a greater than 90% success rate for both primary and repeat procedures (SIU; Grade A). For longer strictures (2 to 4 cm), EPA is more likely to be successful if the stricture resides in the proximal bulb rather than the penile or distal bulbar urethra (SIU; Grade B). For strictures greater than 2 cm in the distal bulbar urethra or penile urethra, augmentation procedures should be utilized in place of EPA since a tension-free anastomosis may not be feasible (SIU; Grade B). Augmentation procedures may have lower success rates than EPA procedures, (SIU; Grade B) (22).

Substitution urethroplasty can be used to reconstruct longer strictures in a one stage or multistage approach using buccal mucosa or lingual oral grafts, penile fasciocutaneous flap, or a combination of both (AUA; Grade C). SIU recommends against tubularized graft urethroplasty (SIU; Grade A) and AUA specifies against single-stage tubularized graft urethroplasty (AUA; expert opinion). Grafts are preferred over flaps given greater mobility with grafts and similar success rates when compared to flaps (SIU; Grade B). Oral mucosa is the preferred choice for grafts in urethroplasty (AUA; expert opinion). Scrotal skin, which is associated with high morbidity (SIU; Grade A), and other hair-bearing skin should be avoided (AUA; clinical principal). Allografts, xenografts, or synthetic materials are not recommended outside of experiment protocols (AUA; expert opinion) (SIU; Grade B).

Meatal and fossa navicularis strictures

For meatal and fossa navicularis strictures, the AUA guidelines recommend initial management with dilation or meatotomy (AUA; clinical principal). Recurrent strictures of the meatus or fossa navicularis warrant urethroplasty (AUA; Grade C). In cases of hypospadias-related strictures, an urethroplasty is recommended (SIU; Grade B).

Penile urethral strictures

For penile strictures urethroplasty should be offered upfront (AUA; Grade C). In the case of substitution urethroplasty for penile strictures, onlay flaps should be considered (SIU; Grade B). If strictures are complex, procedures are usually more successful in two as opposed to single stage (SIU; Grade B). The AUA guidelines do not comment specifically on the success of staged procedures outside of the recommendation against single staged tubularized procedures (AUA; expert opinion). There are no definitive recommendations for catheter placement duration after urethroplasty or antibiotic duration after urethroplasty.

Vesicourethral stenosis, bladder neck contracture

Instances of bladder neck contracture as a complication of prostate procedures can be managed with dilation, bladder neck incision, or transurethral resection (AUA; expert opinion). In instances of post-prostatectomy vesicourethral stenosis, dilation, vesicourethral incision, or transurethral resection can be performed (AUA; Grade C) (SIU: Grade C). Open reconstruction is an option in cases where post-prostatectomy vesicourethral anastomotic stenosis is recalcitrant (AUA; Grade C).

Lichen sclerosus

In cases of suspected LS, clinicians may perform biopsy to confirm a diagnosis. In cases where cancer is suspected, biopsy must be performed (AUA; clinical principal). In cases were LS is in early stages and confined to the foreskin or glans, short-term topical steroids or circumcision should be considered (SIU: Grade A). For urethral strictures secondary to LS, genital skin should not be used when reconstruction is performed (AUA; Grade B). Instead, oral mucosa grafts are the preferred substitution material for LS-related strictures (23). Substitution urethroplasty utilizing bladder or colonic mucosa is discouraged (SIU; Grade C). Long-term follow-up is necessary for men and women with LS due to the increased potential for malignant transformation (SIU: Grade B).

Alternatives to urethroplasty

As an alternative to urethroplasty, the AUA guidelines support a perineal urethrostomy (AUA; Grade C). Permanent urethral stenting is not recommended in management of urethral strictures if patients are candidates for urethral reconstruction (SIU; Grade A). Permanent stenting may be considered in patients who cannot tolerate urethroplasty or intermittent self-dilation (SIU; Grade B). There are prostatic stents that, although backed by limited data, have been shown to have short-term success in brachytherapy patients (24) and patients with benign prostatic obstruction (25).

Post-operative follow up

For all procedures utilized to treat urethral strictures including DVIU, urethral dilation, or urethroplasty, it is important to monitor for stricture recurrence (AUA; expert opinion). Assessment with urethrography or urethroscopy can be used to determine recurrence (SIU; Grade A). Experts acknowledge that there is no gold standard for post-operative screening protocols but recommend a combination of patient symptom assessment, noninvasive test such as uroflowmetry, cystoscopy and/or RUG/VCUG (26,27).

Discussion/comments

When comparing the AUA and the SIU guidelines on urethral stricture, there are very few discrepancies. Perhaps the most notable differences are concern use of repeat DVIU or urethral dilation after an initial failed attempt. SIU guidelines state that there are instances where repeat DVIU or urethral dilation can be indicated, and they give a range of time at which stricture recurrence post procedure mandates an urethroplasty (less than 3 to 6 months). The AUA guidelines definitively state that repeat endoscopic procedures should not be offered as an alternative to urethroplasty, and they do not mention time of stricture recurrence as a factor.

Although few, the discrepancies between the recommendations offered by the two guidelines can be best explained by varying interpretations of the literature and available evidence on urethral strictures. It is important to note the difference in time of publication between the two guidelines. The AUA guidelines were published in 2016 and the SIU guidelines were published in 2010. Therefore, the cumulative body of evidence available at the time of publication of each guideline differs by six years. Newer studies substantiating effectiveness of urethroplasty relative to endoscopic procedures for urethral stricture (28,29) may explain the more current AUA guidelines recommendation against repeat DVIU/dilations. However, the lack of definitive, high quality evidence to support a substantial portion of the guidelines hinders the formulation of unvarying and indisputable best practice recommendations.

The AUA guidelines specify a need for standardized research terms to allow for comparison between centers, multiple criteria for treatment success, improved duration and follow up criteria, and multi-institutional collaboration. They make recommendations for further research into etiology of urethral strictures, improved and unified educational efforts for patients and health care practitioners, and consensus treatment of LS. In addition, they point out knowledge gaps in autologous graft material, anti-proliferative injections, erectile dysfunction, prophylactic antibiotics, and ideal tissue determination for substitution urethroplasty.

Conclusions

Overall there is a need for more high quality research in the work up, management, and follow up care of urethral stricture. There is very few large scale, multi-institutional studies leading to consensus high-grade recommendations. Continually improving evidence quality will yield future guidelines with more robustly supported and aligned recommendations.